DRKS00011801招募中不适用
Multicenter, cross-sectional study investigating the prevalence of defined Clostridium difficile infection (CDI) protective candidate components of the intestinal microbiota - CROSSDIFF
MHH OE68100 个研究点目标入组 500 人开始时间: 2018年1月25日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Inpatients with indication for the C. difficile diagnostics with positive (cases) or negative (controls) results, informed consent from patients after patient education
排除标准
- •CDI or suspected CDI within 30 days prior to enrollment; diseases which prevent candidates to understand the nature and the consequences of the clinical trial; indications for protocol non-compliance
研究者
相似试验
招募中
不适用
A multicenter retrospective study investigating the safety and efficacy of immune checkpoint inhibitors in lung cancer with interstitial pneumoniaung cancer with interstitial pneumoniaJPRN-UMIN000043974Toho University200
已完成
不适用
Comparison of SIRS criteria and qSOFA score for identifying sepsis in the Emergency DepartmentsepsisNL-OMON23850none750
已完成
不适用
A Multicenter retrospective study to investigate the clinical significance of "suspicious for malignancy" on peritoneal washing cytology in resected pancreatic cancerPatients diagnosed with resectable (R) or borderline resectable (BR) pancreatic cancer according to the General Rules for the Study of Pancreatic Cancer 7th edition written by Japan Pancreas Society, who performed upfront surgery, and diagnosed as suspicious or Class III (difficult to differentiate), Class IV (suspicious of malignancy), or Class V (positive/malignant) by peritoneal washing cytology on laparotomy.JPRN-UMIN000046824niversity of Toyama400
招募中
Unknown
SPECTACLE studyRectal cancerJPRN-jRCTs032230212Watanabe Jun400
尚未招募
不适用
A multi-center, single arm, prospective study of the WallFlex biliary partially covered stent for the palliative treatment of malignant bile duct obstruction.Malignant biliary obstructionmalignant obstruction of the biliary tract10019815NL-OMON30737Boston Scientific Corporation18